Site Directory

Home


Eczema

Atopic Eczema

Contact Eczema

Light Sensitive Eczema

Juvenile Plantar Eczema

Eczema Craquele

Eczema Herpeticum

Infantile Eczema

Adult Seborrheic Eczema

Varicose Eczema

Discoid Eczema

Dyshidrotic Eczema


Psoriasis

Guttate Psoriasis

Palmoplantar Psoriasis

Plaque Psoriasis

Inverse Psoriasis

Erythrodermic Psoriasis

Pustular Psoriasis

Nail Psoriasis

Psoriatic Arthritis

Scalp & Ear Psoriasis


Dermatitis

Atopic Dermatitis

Contact Dermatitis

Stasis Dermatitis

Seborrheic Dermatitis

Treatments


Summary


Clinical Trials Resource Center



Rosacea


Contact Us

Clinical Trials Resource Center


Therapeutic Areas: Dermatology | Immunology | Family Medicine

Atopic Dermatitis Clinical Trials


A listing of Atopic Dermatitis medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

Alabama

Anniston :

A clinical trial seeking patients for a research study for the treatment of Atopic Dermatitis

Arizona

Tucson : Physicians Institute

A clinical research study of Photocil for Atopic Dermatitis and Placebo - Sunscreen (SPF 2) for the treatment of Atopic Dermatitis

California

Costa Mesa : Call for Information (Investigational Site 0028) Updated

A clinical trial to evaluate treatments using MK-8226 and Placebo for patients with Atopic Dermatitis

Colorado

Denver : Call for Information (Investigational Site 0010) Updated

A clinical trial to evaluate treatments using MK-8226 and Placebo for patients with Atopic Dermatitis

Florida

Tampa : Olympian Clinical Research

Do you have Atopic Dermatitis and have been treated with Protopic (tacrolimus ointment)?

Georgia

Stockbridge : Clinical Research Atlanta New

A Multicenter, Randomized, Double-Blind, Vehicle-Controlled Study of the Safety and Efficacy of XXXXX Topical Ointment, 2% in Children and Adolescents (Ages 2–17 Years) With Atopic Dermatitis

Illinois

Arlington Heights :

A clinical trial seeking patients for a research study for the treatment of Atopic Dermatitis

Chicago : Northwestern University, Department of Dermatology

A clinical trial seeking patients for a research study for the treatment of Eczema or Atopic Dermatitis

Chicago : Call for Information (Investigational Site 0003) Updated

A clinical trial to evaluate treatments using MK-8226 and Placebo for patients with Atopic Dermatitis

Indiana

Indianapolis :

A clinical trial seeking patients for a research study for the treatment of Atopic Dermatitis

New York

New York : Call for Information (Investigational Site 0002) Updated

A clinical trial to evaluate treatments using MK-8226 and Placebo for patients with Atopic Dermatitis

North Carolina

Charlotte :

A clinical trial seeking patients for a research study for the treatment of Atopic Dermatitis

Winston-Salem : Wake Forest University Health Sciences

A clinical study for patients with Atopic Dermatitis

Ohio

Cleveland :

A clinical trial seeking patients for a research study for the treatment of Atopic Dermatitis

Gahanna : Ohio State University

Patients are needed to participate in a clinical research study evaluating CLn BodyWash and Cetaphil Daily Facial Cleanser for the treatment of Eczema, Hand Eczema or Atopic Dermatitis

Oregon

Portland : Oregon Health & Science University Center for Health & Healing

A clinical study for patients with Atopic Dermatitis

Portland : Oregon Health & Science University, Department of Dermatology

A clinical trial to evaluate treatments using emollient (Cetaphil cream) for patients with Atopic Dermatitis

Portland : Call for Information (Investigational Site 0009) Updated

A clinical trial to evaluate treatments using MK-8226 and Placebo for patients with Atopic Dermatitis

Portland : Oregon Health & Science University Department of Dermatology

A Phase 4 clinical study for patients with Atopic Dermatitis

Pennsylvania

Philadelphia : Registry

A clinical trial to evaluate treatments using Pimecrolimus for patients with Atopic Dermatitis

South Carolina

Charleston :

A clinical trial seeking patients for a research study for the treatment of Atopic Dermatitis

Texas

San Antonio : Dermatology Clinical Research Center of San Antonio

A Phase II, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Dose Finding, and Efficacy Study of VPD-737 in the Treatment of Subjects with Chronic Pruritus

Dallas : Call for Information (Investigational Site 0001) Updated

A clinical trial to evaluate treatments using MK-8226 and Placebo for patients with Atopic Dermatitis

Houston : University of Texas Medical School - Houston

A clinical trial seeking patients for a research study for the treatment of Eczema or Atopic Dermatitis

Houston : Houston Medical Center Building

A Phase 4 clinical study for patients with Impetigo, Folliculitis, Secondarily Infected Eczema or Minor Soft Tissue Infections

Australia

Benowa : Novartis Investigative Site

Patients are needed to participate in a clinical research study of QAW039 and Placebo to evaluate Atopic Dermatitis

Phillip : Novartis Investigative Site

Patients are needed to participate in a clinical research study of QAW039 and Placebo to evaluate Atopic Dermatitis

Woolloongabba : Novartis Investigative Site

Patients are needed to participate in a clinical research study of QAW039 and Placebo to evaluate Atopic Dermatitis

Austria

Vienna : MSD ýterreich GmbH Updated

A clinical trial to evaluate treatments using MK-8226 and Placebo for patients with Atopic Dermatitis

Vienna : Novartis Investigative Site

Patients are needed to participate in a clinical research study of QAW039 and Placebo to evaluate Atopic Dermatitis

Belgium

Bruxelles : Novartis Investigative Site

Patients are needed to participate in a clinical research study of QAW039 and Placebo to evaluate Atopic Dermatitis

Leuven : Novartis Investigative Site

Patients are needed to participate in a clinical research study of QAW039 and Placebo to evaluate Atopic Dermatitis

Liège : Novartis Investigative Site

Patients are needed to participate in a clinical research study of QAW039 and Placebo to evaluate Atopic Dermatitis

Bulgaria

Sofia : Novartis Investigative Site

Patients are needed to participate in a clinical research study of QAW039 and Placebo to evaluate Atopic Dermatitis

Canada

Kirkland : Merck Canada Updated

A clinical trial to evaluate treatments using MK-8226 and Placebo for patients with Atopic Dermatitis

Montreal : Innovaderm Research Inc.

Patients are needed to participate in a clinical research study of Tofacitinib ointment 20mg/g and Placebo ointment (Vehicle) to evaluate Dermatitis, Atopic or Eczema, Atopic

Peterborough : SKiN Centre for Dermatology

Patients are needed to participate in a clinical research study of Tofacitinib ointment 20mg/g and Placebo ointment (Vehicle) to evaluate Dermatitis, Atopic or Eczema, Atopic

Quebec : Centre de Recherche de Dermatologique du Quebec metropolitain

Patients are needed to participate in a clinical research study of Tofacitinib ointment 20mg/g and Placebo ointment (Vehicle) to evaluate Dermatitis, Atopic or Eczema, Atopic

Waterloo : K. Papp Clinical Research

Patients are needed to participate in a clinical research study of Tofacitinib ointment 20mg/g and Placebo ointment (Vehicle) to evaluate Dermatitis, Atopic or Eczema, Atopic

China

Beijing :

A clinical trial seeking patients for a research study for the treatment of Moderate/Severe Atopic Dermatitis

Chongqing :

A clinical trial seeking patients for a research study for the treatment of Moderate/Severe Atopic Dermatitis

Guangzhou :

A clinical trial seeking patients for a research study for the treatment of Moderate/Severe Atopic Dermatitis

Shanghai :

A clinical trial seeking patients for a research study for the treatment of Moderate/Severe Atopic Dermatitis

Denmark

Glostrup : Merck Sharp & Dohme Updated

A clinical trial to evaluate treatments using MK-8226 and Placebo for patients with Atopic Dermatitis

Finland

Espoo : MSD Finland Oy Updated

A clinical trial to evaluate treatments using MK-8226 and Placebo for patients with Atopic Dermatitis

Germany

Berlin :

A clinical trial seeking patients for a research study for the treatment of Atopic Dermatitis

Berlin : Universitätsmedizin Charité Berlin, Abteilung für Dermatologie und Allergologie

A Phase 2 clinical study for patients with Skin Alterations Associated With Atopic Dermatitis

Berlin : Novartis Investigative Site

Patients are needed to participate in a clinical research study of QAW039 and Placebo to evaluate Atopic Dermatitis

Bonn : Novartis Investigative Site

Patients are needed to participate in a clinical research study of QAW039 and Placebo to evaluate Atopic Dermatitis

Dusseldorf :

A clinical research study of VLY-686 and Placebo for the treatment of Treatment-resistant Pruritus Associated With Atopic Dermatitis

Gera :

A clinical trial seeking patients for a research study for the treatment of Atopic Dermatitis

Haar : Merck Sharp & Dohme GmbH Updated

A clinical trial to evaluate treatments using MK-8226 and Placebo for patients with Atopic Dermatitis

Hamburg :

A clinical trial seeking patients for a research study for the treatment of Atopic Dermatitis

Hamburg : bioskin GmbH

Patients are needed to participate in a clinical research study evaluating pimecrolimus 10 mg/g cream and Vehicle cream for the treatment of Atopic Dermatitis

Hannover : Division for Immunodermatology and Allergy Research Clinic for Dermatology, Allergy and Venereology Hannover Medical School

A clinical research study of SB011, 2 % (Water/Oil/Water) emulsion of hgd40 and Multiple W/O/W formulation, active ingredient-free vehicle for the treatment of Mild to Moderate Atopic Dermatitis

Muenster : Novartis Investigative Site

Patients are needed to participate in a clinical research study of QAW039 and Placebo to evaluate Atopic Dermatitis

Munster :

A clinical research study of VLY-686 and Placebo for the treatment of Treatment-resistant Pruritus Associated With Atopic Dermatitis

Münster : Universitätsklinikum Münster, Klinik für Hautkrankheiten

A Phase 2 clinical study for patients with Skin Alterations Associated With Atopic Dermatitis

Japan

Chitose-shi :

A clinical trial seeking patients for a research study for the treatment of Atopic Dermatitis

Eniwa-shi :

A clinical trial seeking patients for a research study for the treatment of Atopic Dermatitis

Fukuoka :

A clinical research study of Dupilumab (REGN668/ SAR231893) and Placebo for the treatment of Atopic Dermatitis

Hokkaido :

A clinical research study of Dupilumab (REGN668/ SAR231893) and Placebo for the treatment of Atopic Dermatitis

Saitama :

A clinical research study of Dupilumab (REGN668/ SAR231893) and Placebo for the treatment of Atopic Dermatitis

Sapporo : For additional information regarding investigative sites for this trial, contact Kyowa Hakko Kirin

Patients are needed to participate in a clinical research study evaluating KHK4577 for the treatment of Atopic Dermatitis

Sapporo-shi :

A clinical trial seeking patients for a research study for the treatment of Atopic Dermatitis

Tokyo, Bunkyo-ku :

A clinical research study of Dupilumab (REGN668/ SAR231893) and Placebo for the treatment of Atopic Dermatitis

Tokyo, Chiyoda-ku :

A clinical research study of Dupilumab (REGN668/ SAR231893) and Placebo for the treatment of Atopic Dermatitis

Tokyo, Nakano-ku :

A clinical research study of Dupilumab (REGN668/ SAR231893) and Placebo for the treatment of Atopic Dermatitis

Tokyo, Nerima-ku :

A clinical research study of Dupilumab (REGN668/ SAR231893) and Placebo for the treatment of Atopic Dermatitis

Tokyo, Shibuya-ku :

A clinical research study of Dupilumab (REGN668/ SAR231893) and Placebo for the treatment of Atopic Dermatitis

Tokyo, Shinagawa-ku :

A clinical research study of Dupilumab (REGN668/ SAR231893) and Placebo for the treatment of Atopic Dermatitis

Tokyo, Shinjuku-ku (2 locations) :

A clinical research study of Dupilumab (REGN668/ SAR231893) and Placebo for the treatment of Atopic Dermatitis

Tokyo, Suginami-ku (2 locations) :

A clinical research study of Dupilumab (REGN668/ SAR231893) and Placebo for the treatment of Atopic Dermatitis

Yokohama :

A clinical research study of Dupilumab (REGN668/ SAR231893) and Placebo for the treatment of Atopic Dermatitis

Korea, Republic of

Seoul : Catholic Medical Center

Patients are needed to participate in a clinical research study of Stem cells to evaluate Atopic Dermatitis

Netherlands

Amsterdam : Novartis Investigative Site

Patients are needed to participate in a clinical research study of QAW039 and Placebo to evaluate Atopic Dermatitis

Groningen : Novartis Investigative Site

Patients are needed to participate in a clinical research study of QAW039 and Placebo to evaluate Atopic Dermatitis

Utrecht : Novartis Investigative Site

Patients are needed to participate in a clinical research study of QAW039 and Placebo to evaluate Atopic Dermatitis

Romania

Bucharest : Novartis Investigative Site

Patients are needed to participate in a clinical research study of QAW039 and Placebo to evaluate Atopic Dermatitis

Singapore

Singapore : National Skin Centre

A clinical study for patients with Atopic Dermatitis

South Africa

Durban : Novartis Investigative Site

Patients are needed to participate in a clinical research study of QAW039 and Placebo to evaluate Atopic Dermatitis

Spain

Barcelona : Fundación Teknon

A clinical trial seeking patients for a research study for the treatment of Atopic Dermatitis

Taiwan

New Taipei City : Taipei Hospital, Department of Health, Taiwan, R.O.C.

Patients are needed to participate in a clinical research study evaluating LP GMNL-133 capsule, LF GM-090 capsule, LP GMNL-133 +LF GM-090 capsule and Placebo for the treatment of Atopic Dermatitis or Asthma

United Kingdom

Leeds : Covance Clinical Research Unit, Hyde Street, Leeds, UK

A Phase 1 clinical study for patients with Atopic Dermatitis

Liverpool : Covance Royal Liverpool Clinical Research Unit

A Phase 1 clinical study for patients with Atopic Dermatitis

Manchester, Lancashire, Midlands, Wales, Scotland : Synexus

Patients are needed to participate in a clinical research study of CT327 ointment and placebo to evaluate Atopic Dermatitis

Sheffield : Professor Michael Cork

A clinical trial to evaluate treatments using OC000459 for patients with Atopic Dermatitis